Keywords: bi, baminercept, enters, ph, iib, trials, drugmaker

BI's baminercept enters Ph IIb trials

Article | 19 November 2007

Print This

US drugmaker Biogen Idec presented strong results from a Phase IIa trial of baminercept (LT(beta)R-Ig or BG9924), the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in